Spots Global Cancer Trial Database for Proteomic Signature in Breast Cancer: Correlation With Tumor Response to Neo-adjuvant Chemotherapy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Proteomic Signature in Breast Cancer: Correlation With Tumor Response to Neo-adjuvant Chemotherapy
Official Title: Analysis of the Proteomic Signature in Breast Cancer Correlated With Tumor Response in Patients Necessitating a Neo-adjuvant Chemotherapy
Study ID: NCT00911911
Conditions
Study Description
Brief Summary: The scope of the trial is to identify proteomic signatures correlated with tumor response to neo-adjuvant chemotherapy.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Intercommunal Hospital, Annemasse, , France
Centre Oscar Lambret, Lille, , France
Hopital Saint Vincent, Lille, , France
Centre Henri Becquerel, Rouen, , France
Geroges PIANTA Hospital, THONON Les BAINS, , France
Contact Details
Name: BONNETERRE Jacques, MD, PhD
Affiliation: Centre Oscar Lambret
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
